The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Subscribe To Our Newsletter & Stay Updated